Howard Hughes Medical Institute’s Aptiv APTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-47
Closed -$3.58K 67
2025
Q4
$3.58K Hold
47
﹤0.01% 407
2025
Q3
$4.05K Sell
47
-2
-4% -$151 ﹤0.01% 380
2025
Q2
$3.34K Buy
+49
New +$3.03K ﹤0.01% 406
2014
Q2
Sell
-3,553
Closed -$241K 181
2014
Q1
$241K Sell
3,553
-1,922
-35% -$123K 0.03% 74
2013
Q4
$329K Buy
5,475
+421
+8% +$24.4K 0.05% 69
2013
Q3
$295K Sell
5,054
-2,364
-32% -$131K 0.05% 69
2013
Q2
$376K Buy
+7,418
New +$348K 0.12% 68

Other funds holding APTV

Howard Hughes Medical Institute's APTV Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Aptiv (APTV) in Q1 2026, closing a stake of 47 shares — an estimated $3.58K sold.

Howard Hughes Medical Institute first reported a position in APTV in Q2 2013 and held it in 7 quarters. The position peaked at $376K in Q2 2013. 707 funds tracked by Wall St. Rank hold APTV as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Aptiv position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 47 Aptiv shares in Q1 2026, an estimated $3.58K.
  • Howard Hughes Medical Institute first reported a position in Aptiv in Q2 2013 and held it in 7 quarters.
  • Howard Hughes Medical Institute's Aptiv position peaked at $376K in Q2 2013.
  • 707 funds tracked by Wall St. Rank held Aptiv as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.